Oura's IPO Path: What We Know (and What It Means for Sleep Tech)

Short version: Oura did not go public on September 29, 2026. It hit pause.

The smart-ring company had a live S-1, a $40–$44 price range, a proposed Nasdaq ticker OURA, and a roadshow aimed at a multi-billion-dollar raise. Then, the same day many watchers expected pricing, it postponed the IPO indefinitely, citing uncertainty in the IPO market — while saying demand for the deal had been strong.

If you sleep with a ring on your finger, or you're deciding between a wearable and a contactless bedside sensor, the useful question isn't "did the stock pop?" It's: what did the filing actually show about the business, and what should a buyer do with that?

Status check (as of Tue Sep 29, 2026 ET)

• IPO completed / trading? No.
• Confidential draft S-1: May 21, 2026 (company announcement)
• Public Form S-1: September 3, 2026 (SEC)
• Amended terms (S-1/A): September 21, 2026 — 50M shares at $40–$44
• Postponement: September 29, 2026 (company statements via TechCrunch / IBTimes)
• Proposed exchange / ticker: Nasdaq Global Select / OURA — applied for, not live

This post sticks to sourced numbers. Rumors get labeled. Invented IPO prices don't belong here.

Disclosure: I founded Komori Care — a contactless sleep wellness monitor in development for a 2027 Kickstarter. General wellness only: not FDA-cleared, not a medical device, no seizure detection (disclaimer). Oura is a wearable ring. Those are different jobs. We can talk about both without pretending they're clones.

What actually happened (timeline)

Oura started in Finland in 2013 (originally JouZen Oy; later Oura Health Oy). The product people know is the Oura Ring — a finger-worn sensor that feeds the Oura App, with most of the interesting software behind a paid Oura Membership.

In October 2025, Oura raised over $900 million in a Fidelity-led round at a roughly $11 billion valuation (company Business Wire). Then it prepared for U.S. public markets:

1. January–March 2026 — Redomiciled: Delaware parent Oura Inc. became the top company; Finnish OpCo became a subsidiary (reorganization completed March 31, 2026, per the S-1).
2. May 21, 2026 — Confidential draft registration statement submitted to the SEC (company Business Wire).
3. May 28 / June 4, 2026 — Oura Ring 5 announced / started shipping. Company says it's about 40% smaller than Ring 4; base finishes $399, premium $499 (Oura blog / CNBC).
4. September 3, 2026 — Public Form S-1 filed. Reuters covered the revenue jump and the planned Nasdaq listing under OURA.
5. September 21, 2026 — Amended filing set terms: 50 million shares at $40–$44. Max raise before overallotment ≈ $2.2 billion. Company selling 13.5M; existing holders selling 36.5M. Underwriters had an option for up to 7.5M more from selling stockholders (IBTimes / Bloomberg coverage of the amendment).
6. September 29, 2026 — Postponed. CEO Tom Hale said the company has "the luxury of choosing our moment" (TechCrunch).

So if someone tells you "Oura IPOd today," they're wrong as of this writing. The path is public. The listing isn't.

The filed terms — and why the structure matters

Assume the Sep 21 range for a second. At $44, 50 million shares is about $2.2B of stock changing hands. That headline is easy to misread.

Most of those shares were not primary capital for Oura.

Of the 50 million:

• 13.5 million — company primary (Oura gets cash, after fees)
• 36.5 million — selling stockholders (early investors / employees get liquidity; company gets $0)

That's a classic late-stage venture exit shape: the market was being asked to buy out a big slab of private holders at a premium to the October 2025 private mark, while the company itself raised a smaller primary sleeve — partly, filings and press said, to cover employee tax / RSU settlement obligations rather than to refill an empty treasury. Cash on the balance sheet at June 30 was already about $372 million (S-1).

Valuation: Press math on the filed range put fully diluted value around $14–$15.6 billion depending on how you count shares. Treat that as filed-terms implication, not a trading market cap. There is no public float yet.

Banks on the cover of the preliminary prospectus included Goldman Sachs, Morgan Stanley, J.P. Morgan, Allen & Company, and Jefferies, among others (S-1).

None of that means the business is "done." It means the deal was as much a liquidity event as a growth raise — and when the IPO window felt shaky, they could wait.

What the S-1 actually says about the business

This is the part sleep-tech buyers should care about more than ticker theater.

Hardware + membership (not one or the other)

Oura sells rings, then converts wearers into Paid Members. In the U.S., membership is $5.99/month or $69.99/year (S-1). Historically, the filing says more than 94% of ring activations convert to paid membership after the trial, with weighted-average 12-month retention around 85% as of June 30, 2026.

For the nine months ended June 30, 2026 (S-1):

Membership grew 121% year over year in that period and carried an 89% membership gross margin. Hardware still pays most of the bills. The subscription is the high-margin layer that makes the model look like a platform, not a gadget dump.

Growth and profitability claims (quoted from the filing)

Same nine-month window vs prior year:

• Revenue $1.21B, up 74% from $697.6M
• GAAP net income $60.8M vs $1.6M
• Adjusted EBITDA $106.7M vs $83.5M
• Gross margin 55% vs 51%

Full fiscal 2025 (year ended Sep 30, 2025): revenue $907.9M, up from $406.8M in fiscal 2024.

Operating scale as of June 30, 2026: 5.0 million Paid Members (vs 2.5M a year earlier); 3.6 million rings sold in the trailing twelve months; presence in 56 markets.

After the filing, company comments relayed by TechCrunch on postponement day put paid members at 5.7 million and guided to roughly 90% full-year revenue growth vs the $907.9M baseline. Label those as company statements via press, not new audited line items.

Ring 5 is the current hardware story

Ring 5 is the product the filing and the roadshow leaned on: smaller titanium ring, week-class battery claim, same membership flywheel. If you buy an Oura in late 2026, you're mostly buying into that generation plus the app/membership stack — not into a stock ticker.

Competitive context without the fan fiction

Oura's own S-1 frames competition broadly: smartwatches (Apple, Google/Fitbit, Samsung), fitness wearables (Garmin, Coros, Whoop), and software health apps. Inside smart rings, third-party research firms (Omdia, cited in secondary coverage) have put Oura in the large majority of global shipments in 2025 — treat share percentages as research estimates, not something to invent more precisely than the sources allow.

What matters for a buyer is the job:

We already wrote the product-level comparison here: Oura vs contactless sleep monitors. The IPO drama doesn't change that table.

And if you've ever worn two trackers on the same night and watched them disagree — that's normal. They're estimators. See Put Two Sleep Trackers On. They Won't Agree..

What the IPO path means for sleep-tech buyers

Not investment advice. Buyer advice.

1. More disclosure is useful — when it exists.
A public Oura would eventually mean 10-Qs, clearer membership mix, and less rumor. A postponed Oura still left you an S-1. Read that before you read Twitter valuation threads.

2. Listing timing ≠ product quality.
Postponing a deal because the IPO market feels ugly is not the same as "Ring 5 flopped." The filing showed growth and positive net income in the latest nine-month period. The company says it can wait. Believe the pause is about markets until evidence says otherwise.

3. Membership is part of the price.
Sticker price on the ring is incomplete. Add the membership if you want the full app. That's not a gotcha — it's the model. Compare three-year cost of ownership the same way you'd compare any subscription wearable.

4. Buy the job, not the headline.
Need individualized biometrics you'll actually wear? A ring (or a watch) is the lane. Hate wearing things to bed, care about position/presence/privacy of a camera-free bedroom? Contactless is the lane. Many power users will want both — finger physiology plus bed context — the same way you might use a watch and a bedroom sensor without declaring a holy war.

5. Wellness language still applies.
Consumer sleep gadgets — rings included — are mostly general wellness tools unless a specific feature is cleared for a medical use. Don't upgrade your anxiety because a prospectus used the word "health" a lot. If your sleep is falling apart, talk to a clinician. Gadgets are trends and prompts, not diagnoses. Related: why we don't show a single sleep score.

Where Komori fits (softly)

I'm building Komori as a contactless bedside system for 2027 — designed to log sleep position, movement, bed exits, and room conditions without a wearable and without a bedroom camera. Kickstarter is the plan. Waitlist if you want a ping when it's real.

It is not trying to out-Oura Oura on finger PPG. If you love your ring, keep it. If you want bed-level context the ring doesn't see — especially position through blankets — that's the complementary slot. Shipping today for "no wearable" mats is a different foil (Withings and friends); we covered that in the contactless roundup.

No hard pitch. Just: different sensor, different question.

FAQ

Did Oura IPO on September 29, 2026?
No. It postponed the planned offering that day, citing IPO-market uncertainty (TechCrunch / IBTimes).

Is the ticker OURA trading?
Not as of this post. Oura applied to list on Nasdaq Global Select under OURA. Application ≠ listing.

What raise and valuation were on the table?
Amended terms: 50M shares at $40–$44, up to about $2.2B before overallotment. Press implied ~$14–$15.6B fully diluted at those terms. Filed terms only — not a priced IPO.

How much was primary vs secondary?
13.5M company / 36.5M selling stockholders. Most of the float was liquidity for existing holders.

Is Oura profitable?
For the nine months ended June 30, 2026, the S-1 reports $60.8M GAAP net income on $1.21B revenue. That is not a guarantee of future quarters.

What's the latest ring?
Oura Ring 5 (announced May 28, 2026; shipping from June 4). Company list prices: $399 base / $499 premium finishes.

Does an IPO change whether I should buy a ring?
Barely. Decide on wearability, membership cost, and the metrics you actually use. The S-1 is a better product diligence packet than a first-day ticker chart would be anyway.

Ring vs contactless — who "wins"?
Wrong framing. Rings win individualized biometrics. Contactless wins no-wearable bed context. See Oura vs contactless.

Is Komori a medical device?
No. General wellness; not FDA-cleared; not for diagnosis or seizure detection. Coming 2027.

Bottom line

Oura's public filing was a rare clear look under the hood of the category-defining smart ring: hardware still majority revenue, membership the high-margin flywheel, Ring 5 in market, and a real attempt to list under OURA that got parked on September 29, 2026.

For sleep-tech buyers, the actionable takeaway is dull and useful: read the business, buy the job, ignore the fake "they went public" headlines. Keep your ring if it earns its finger. Add contactless if you want the bed's side of the story. And if you're curious about what we're building for 2027, the waitlist is enough — no ticker required.

---

Sources (primary)

• Oura Inc. Form S-1 (filed Sep 3, 2026)
• TechCrunch — IPO postponed (Sep 29, 2026)
• IBTimes — postponement + terms (Sep 29, 2026)
• Reuters — public S-1 filing (Sep 3, 2026)
• Business Wire — confidential S-1 (May 21, 2026)
• Oura — Introducing Ring 5 (May 28, 2026)
• CNBC — Ring 5 pricing / ship date
• Business Wire — Series E >$900M / ~$11B (Oct 2025)

Komori Care is a contactless sleep wellness monitor in development — no wearable, no camera. Kickstarter planned for 2027. Join the waitlist if you want a note when we launch.